Please assess the completion status of the following clinical trial:

Trial Title: Doubleblinded RCT of the Omnilux on Lower Extremity Surgical Wounds Left to Heal by Second Intention

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Surgical defect on the lower extremity left to heal by secondary intention.~* If women of child bearing potential, contraceptive measures should be used~* Maximum size of wound is 5cm x5cm; there is no minimum size for the wound.~Exclusion Criteria:~* History of porphyria photosensitive eruptions, diabetes mellitus, history of venous insufficiency, known history of peripheral arterial disease (ABI \<0.8)~* Use of any ointments or creams containing photosensitizers (coumarins or porphyrins) should be discontinued for 2 weeks prior~* Use of systemic or local retinoids for the past 6 months.~* Current pregnancy or breastfeeding~* History of metastatic cancer.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Sham Group (Group 1) (Type: SHAM_COMPARATOR): This group will receive 4 sessions of Omnilux sham light, starting 1 week after the surgery. Frequency: 1 session every week (+/- 3 days), for 4 weeks. Session duration: 20 minutes
- Treatment group (Group 2) (Type: EXPERIMENTAL): This group will receive 4 treatment sessions with Omnilux 633nm LED, starting 1 week after the surgery. Frequency: 1 session every week (+/- 3 days), for 4 weeks. Session duration: 20 minutes

Based on this trial design, predict the completion outcome and termination type (if applicable).